Researcher.Life Logo

Current Pharmaceutical Design : Impact Factor & More

eISSN: 1873-4286pISSN: 1381-6128

Aims and Scope of Current Pharmaceutical Design

Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less

Key Metrics

CiteScore
5.8
H-Index
176
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Pharmaceutical Design

Current Pharmaceutical Design Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Weekly
General Details
LanguageEnglish
FrequencyWeekly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Pharmaceutical Design ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Pharmaceutical Design

Machine Learning-Enabled Exploration of Bryophyllum Pinnatum Phytoconstituents for Urolithiasis Management: Molecular Docking, MMGBSA Analysis, ADMET Profiling, MD simulations, and Toxicity Assessment.
  • 13 May 2026
  • Current pharmaceutical design
Gabapentin and Pregabalin Overdoses and Their Management: An Update.
  • 13 May 2026
  • Current pharmaceutical design
Mechanistic Insights into Xihuang Wan against Bladder Cancer via PI3K/ AKT/BCL2-Mediated Apoptosis Inhibition: Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations and Experimental Validation.
  • 13 May 2026
  • Current pharmaceutical design
Extracellular Vesicles in Alzheimer's Disease: Mechanisms, Immunotherapy Links, and Clinical Translation.
  • 13 May 2026
  • Current pharmaceutical design
Cell-free DNA Methylation Analysis, a Noninvasive Biomarker for Detection, Prediction, Classification, and Treatment Monitoring for Brain Tumors.
  • 12 May 2026
  • Current pharmaceutical design
Efficacy of Pimpinella anisum L. in Menopausal Women with Psychological Symptoms: A Randomized Controlled Study Integrated with Machine Learning Analysis.
  • 12 May 2026
  • Current pharmaceutical design
Machine Learning-Enabled Exploration of Bryophyllum Pinnatum Phytoconstituents for Urolithiasis Management: Molecular Docking, MMGBSA Analysis, ADMET Profiling, MD simulations, and Toxicity Assessment.
  • 13 May 2026
  • Current pharmaceutical design
Gabapentin and Pregabalin Overdoses and Their Management: An Update.
  • 13 May 2026
  • Current pharmaceutical design
Mechanistic Insights into Xihuang Wan against Bladder Cancer via PI3K/ AKT/BCL2-Mediated Apoptosis Inhibition: Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations and Experimental Validation.
  • 13 May 2026
  • Current pharmaceutical design
Extracellular Vesicles in Alzheimer's Disease: Mechanisms, Immunotherapy Links, and Clinical Translation.
  • 13 May 2026
  • Current pharmaceutical design
Cell-free DNA Methylation Analysis, a Noninvasive Biomarker for Detection, Prediction, Classification, and Treatment Monitoring for Brain Tumors.
  • 12 May 2026
  • Current pharmaceutical design
Efficacy of Pimpinella anisum L. in Menopausal Women with Psychological Symptoms: A Randomized Controlled Study Integrated with Machine Learning Analysis.
  • 12 May 2026
  • Current pharmaceutical design

FAQs on Current Pharmaceutical Design